Cadila Healthcare has submitted a copy of Press Release dated January 19, 2017 titled ‘Zydus Cadila acquires Sentynl Therapeutics Inc., a US based specialty pharmaceutical company’.
The above information is a part of company’s filings submitted to BSE.